CASC3 and plasma cell myeloma: BTZ is a specific inhibitor of the 26S proteasome subunit, which induces human tumor cell apoptosis through various mechanisms, exhibits good clinical activity in multiple myeloma, lymphoma, breast cancer, lung cancer, and CRC (Liu et al., 2021), and can induce ICD.